To study the efficacy of tuvarakadi cream in the managment of eczema in children

Not yet recruiting

• Conditions: Atopic dermatitis, unspecified. Ayurveda Condition: CARMADALA-KUSHTHAH,

• Registration Number: CTRI/2025/04/085361
• Lead Sponsor: Sane Guruji Arogya Kendra

Brief Summary

This is a clinical study to assess the efficacy of tuvrakadi cream in the management of charmadala in the age group of 6 months to 2 year children with special reference to atopic dermatitis

Primary objective is to study the effectiveness of tuvarakadi cream as bahirparimarjana in the management of charmadala in kshreerap and kshreeranada balak in the timespan of 14 days.

Assessment of signs and symptoms will be done and observation will be drawn from the outcome of patient.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-04-05
• Last Update Posted: 2025-04-22

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patient having classical signs and symptoms of Vataj Charmadala.
• Infants and toddlers between the Age group 6 months to 2 years.
• Patients irrespective of sex, religion and socioeconomical status.
• Patient of the parent who will give written consent will be included.

Exclusion Criteria

• Charmadala associated with sphota.
• Patient with associated skin infections such as herpes simplex, herpes zoster, scabies, impetigo or lichen simplex chronicus and congenital syphilis.
• Children having any other associated illness such as acute exacerbation of asthma or hey fever.
• Children admitted in NICU and PICU.
• Children receiving phototherapy.
• Patient with more than 60 % body surface involvement.
• Patient taking treatment from any other pathy for the same problem.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate efficacy of Tuvarakadi cream in the management of charmadala	Treatment will be given for 14 days | Tuvarakadi will be given to the patient for external application. | Follow up and assessment will be done after7th day and 14th day. | Final observation will be recorded after | completion of treatment.
in the age group of 6 months to 2 year old children in time span of 14 days	Treatment will be given for 14 days | Tuvarakadi will be given to the patient for external application. | Follow up and assessment will be done after7th day and 14th day. | Final observation will be recorded after | completion of treatment.

Secondary Outcome Measures

Name	Time	Method
To observe adverse effect & evaluate the safety of Tuvarakadi cream in the management of charmadala in	the age group of 6 months to 2 year old children in the time span of 14 days

Trial Locations

Locations (1)

Sane guruji arogya kendra; 🇮🇳 Pune, MAHARASHTRA, India

Sane guruji arogya kendra

🇮🇳Pune, MAHARASHTRA, India

Dr Rashmi Meshram

Principal investigator

rashmimeshram99@gmail.com